Postoperative reduction of anti‐seizure medication is associated with cognitive improvement in seizure‐free patients after anterior temporal lobectomy
Epilepsia · 2026
DOI: 10.1002/epi.70395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Kazushi Ukishiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epileptology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Anterior Temporal Lobectomy, Anticonvulsants, Epilepsy, Temporal Lobe, Drug Resistant Epilepsy. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine whether postoperative reduction of anti‐seizure medication (ASM) burden is associated with cognitive improvement after anterior temporal lobectomy (ATL) in seizure‐free patients.
Methods
We retrospectively analyzed data for adult patients with drug‐resistant temporal lobe epilepsy who underwent unilateral ATL between March 2013 and January 2025. Analyses were restricted to patients achieving complete freedom from seizures (Engel Class I) at 1 year. ASM burden was quantified using the prescribed daily dose/defined daily dose ratio, and the reduction rate was calculated. Preoperative and 1‐year postoperative neuropsychological outcomes, including full‐scale intelligence quotient (FSIQ) and domain‐specific indices, were assessed. The effect of ASM reduction on cognitive change was evaluated using a doubly robust estimation framework integrating inverse probability of treatment weighting with multivariable outcome regression. Robustness and potential dose–response relationships were assessed via sensitivity analyses, analysis of covariance (ANCOVA), and categorical modeling.
Results
Fifty‐seven seizure‐free patients were included in the primary analysis (median age at surgery, 32 years; 33 female). Greater ASM reduction was significantly associated with improved working memory (WM) ( β = .066, p = .001). A positive but non‐significant trend was observed for FSIQ ( β = .021, p = .062). A dose–response relationship was identified, with greater ASM reduction associated with progressively greater improvement in WM ( p = .013). Findings were consistent across sensitivity and ANCOVA analyses. Significance Postoperative ASM reduction was associated with domain‐specific cognitive improvement following ATL, particularly in WM. These findings support ASM tapering as a potentially modifiable factor influencing postoperative cognitive outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epileptology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
ORCID-Profile: Kazushi Ukishiro, Shin-Ichiro Osawa, Maimi Ogawa, Makoto Ishida, Takafumi Kubota, Kazutoshi Konomatsu, Hidenori Endo, Kazutaka Jin
Zitieren
APA
Ukishiro, K., Osawa, S. I., Ogawa, M., Ishida, M., Kubota, T., Konomatsu, K., Endo, H., & Jin, K. (2026). Postoperative reduction of anti‐seizure medication is associated with cognitive improvement in seizure‐free patients after anterior temporal lobectomy. Epilepsia. https://doi.org/10.1002/epi.70395
Vancouver
Ukishiro K, Osawa SI, Ogawa M, Ishida M, Kubota T, Konomatsu K, et al. Postoperative reduction of anti‐seizure medication is associated with cognitive improvement in seizure‐free patients after anterior temporal lobectomy. Epilepsia. 2026. doi:10.1002/epi.70395
BibTeX
@article{Ukishiro2026,
author = {Ukishiro, Kazushi and Osawa, Shin-Ichiro and Ogawa, Maimi and Ishida, Makoto and Kubota, Takafumi and Konomatsu, Kazutoshi and Endo, Hidenori and Jin, Kazutaka},
title = {Postoperative reduction of anti‐seizure medication is associated with cognitive improvement in seizure‐free patients after anterior temporal lobectomy},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70395}
}
EUVIMED